Canopy Immuno-Therapeutics vs Upstream Bio
Canopy Immuno-Therapeutics vs Upstream Bio, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Canopy Immuno-Therapeutics is on 17/100 and Upstream Bio on 61/100.
Where each one leads
Canopy Immuno-Therapeutics
Leads on none of the measures we hold for both companies.
Upstream Bio
- our overall score: 61/100 against 17/100
- agent readiness: 39/100 against 21/100
- domain rating: 32/100 against 3/100
At a glance
| Measure | Canopy Immuno-Therapeutics | Upstream Bio |
|---|---|---|
| What it is | Developing novel immunotherapies for autoimmune diseases and life-threatening allergies. | Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases. |
| Category | Life Sciences, Immunotherapy, Immunology, Biotech | Life Sciences, Therapeutics, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 2019 | 2021 |
| Headquarters | Not published | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Canopy Immuno-Therapeutics | Upstream Bio |
|---|---|---|
| Employees | Not published | 75 |
| Headcount growthLast 12 months | Not published | +43.4% |
| Total funding | Not published | $400M |
| Latest round | Pre-Seed | Series B |
| LinkedIn followers | Not published | 11,799 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Canopy Immuno-Therapeutics | Upstream Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 17/100 | 61/100 |
| Traction | Not published | 59/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 13/100 | 37/100 |
| Quality | Not published | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 3/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Canopy Immuno-Therapeutics | Upstream Bio |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
Canopy Immuno-Therapeutics vs Upstream Bio: common questions
Which is better, Canopy Immuno-Therapeutics or Upstream Bio?
On our 0-100 score Upstream Bio rates higher (61/100 against 17/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Canopy Immuno-Therapeutics and Upstream Bio compare on the numbers?
Upstream Bio leads on our overall score (61/100 against 17/100), agent readiness (39/100 against 21/100), domain rating (32/100 against 3/100).
Read the full Canopy Immuno-Therapeutics review and pricing or the Upstream Bio review and pricing. You can also browse other Canopy Immuno-Therapeutics alternatives we track.